시장조사 보고서 : 세계의 아미노글리코사이드계 항생제 시장예측 2021년-2026년

■ 영문 제목 : Global Aminoglycosides Antibiotics Market Growth 2021-2026
	■ 상품코드 : LPI-2108K202098 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 8월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 167 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (20명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 아미노글리코사이드계 항생제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (네오마이신, 토브라마이신, 겐타마이신, 아미카신, 에티마이신, 기타)와 용도별 시장규모 (병원, 진료소, 산후 조리 시설, 관공서, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 아미노글리코사이드계 항생제 시장 점유율
- 지역별 아미노글리코사이드계 항생제 시장규모
- 주요지역의 종류별 시장규모 (네오마이신, 토브라마이신, 겐타마이신, 아미카신, 에티마이신, 기타)
- 주요지역의 용도별 시장규모 (병원, 진료소, 산후 조리 시설, 관공서, 기타)
- 미주의 아미노글리코사이드계 항생제 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 아미노글리코사이드계 항생제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 아미노글리코사이드계 항생제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 아미노글리코사이드계 항생제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 아미노글리코사이드계 항생제 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2020 growth of Aminoglycosides Antibiotics will have significant change from previous year. By the most conservative estimates of global Aminoglycosides Antibiotics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1034.2 million in 2019. Over the next five years the Aminoglycosides Antibiotics market will register a 0.6% CAGR in terms of revenue, the global market size will reach US$ 1057.5 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Aminoglycosides Antibiotics market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Neomycin
Tobramycin
Gentamicin
Amikacin
Etimicin
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Clinic
Post Care Facility
Government & Military
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Jemicare
Teva
Novartis
Fangyuan-pharma
Aike Pharmaceutical
Cipla
Pfizer
Fresenius Kabi
Sun Pharma
Hikma
Lannett Company

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Aminoglycosides Antibiotics Consumption 2016-2026
2.1.2 Aminoglycosides Antibiotics Consumption CAGR by Region
2.2 Aminoglycosides Antibiotics Segment by Type
2.2.1 Neomycin
2.2.2 Tobramycin
2.2.3 Gentamicin
2.2.4 Amikacin
2.2.5 Etimicin
2.2.6 Others
2.3 Aminoglycosides Antibiotics Sales by Type
2.3.1 Global Aminoglycosides Antibiotics Sales Market Share by Type (2016-2021)
2.3.2 Global Aminoglycosides Antibiotics Revenue and Market Share by Type (2016-2021)
2.3.3 Global Aminoglycosides Antibiotics Sale Price by Type (2016-2021)
2.4 Aminoglycosides Antibiotics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Post Care Facility
2.4.4 Government & Military
2.4.5 Others
2.5 Aminoglycosides Antibiotics Sales by Application
2.5.1 Global Aminoglycosides Antibiotics Sale Market Share by Application (2016-2021)
2.5.2 Global Aminoglycosides Antibiotics Revenue and Market Share by Application (2016-2021)
2.5.3 Global Aminoglycosides Antibiotics Sale Price by Application (2016-2021)

3 Global Aminoglycosides Antibiotics by Company
3.1 Global Aminoglycosides Antibiotics Sales Market Share by Company
3.1.1 Global Aminoglycosides Antibiotics Sales by Company (2019-2021)
3.1.2 Global Aminoglycosides Antibiotics Sales Market Share by Company (2019-2021)
3.2 Global Aminoglycosides Antibiotics Revenue Market Share by Company
3.2.1 Global Aminoglycosides Antibiotics Revenue by Company (2019-2021)
3.2.2 Global Aminoglycosides Antibiotics Revenue Market Share by Company (2019-2021)
3.3 Global Aminoglycosides Antibiotics Sale Price by Company
3.4 Global Manufacturers Aminoglycosides Antibiotics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aminoglycosides Antibiotics Product Location Distribution
3.4.2 Players Aminoglycosides Antibiotics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Aminoglycosides Antibiotics by Region
4.1 Global Aminoglycosides Antibiotics by Region
4.1.1 Global Aminoglycosides Antibiotics Sales by Region
4.1.2 Global Aminoglycosides Antibiotics Revenue by Region
4.2 Americas Aminoglycosides Antibiotics Sales Growth
4.3 APAC Aminoglycosides Antibiotics Sales Growth
4.4 Europe Aminoglycosides Antibiotics Sales Growth
4.5 Middle East & Africa Aminoglycosides Antibiotics Sales Growth

5 Americas
5.1 Americas Aminoglycosides Antibiotics Sales by Country
5.1.1 Americas Aminoglycosides Antibiotics Sales by Country (2016-2021)
5.1.2 Americas Aminoglycosides Antibiotics Revenue by Country (2016-2021)
5.2 Americas Aminoglycosides Antibiotics Sales by Type
5.3 Americas Aminoglycosides Antibiotics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Aminoglycosides Antibiotics Sales by Region
6.1.1 APAC Aminoglycosides Antibiotics Sales by Region (2016-2021)
6.1.2 APAC Aminoglycosides Antibiotics Revenue by Region (2016-2021)
6.2 APAC Aminoglycosides Antibiotics Sales by Type
6.3 APAC Aminoglycosides Antibiotics Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Aminoglycosides Antibiotics by Country
7.1.1 Europe Aminoglycosides Antibiotics Sales by Country (2016-2021)
7.1.2 Europe Aminoglycosides Antibiotics Revenue by Country (2016-2021)
7.2 Europe Aminoglycosides Antibiotics Sales by Type
7.3 Europe Aminoglycosides Antibiotics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Aminoglycosides Antibiotics by Country
8.1.1 Middle East & Africa Aminoglycosides Antibiotics Sales by Country (2016-2021)
8.1.2 Middle East & Africa Aminoglycosides Antibiotics Revenue by Country (2016-2021)
8.2 Middle East & Africa Aminoglycosides Antibiotics Sales by Type
8.3 Middle East & Africa Aminoglycosides Antibiotics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Aminoglycosides Antibiotics Distributors
10.3 Aminoglycosides Antibiotics Customer

11 Global Aminoglycosides Antibiotics Market Forecast
11.1 Global Aminoglycosides Antibiotics Forecast by Region
11.1.1 Global Aminoglycosides Antibiotics Forecast by Regions (2021-2026)
11.2.2 Global Aminoglycosides Antibiotics Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Aminoglycosides Antibiotics Forecast by Type
11.7 Global Aminoglycosides Antibiotics Forecast by Application

12 Key Players Analysis
12.1 Jemicare
12.1.1 Jemicare Jemicare Company Information
12.1.2 Jemicare Aminoglycosides Antibiotics Product Offered
12.1.3 Jemicare Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Jemicare Main Business Overview
12.1.5 Jemicare Latest Developments
12.2 Teva
12.2.1 Teva Company Information
12.2.2 Teva Aminoglycosides Antibiotics Product Offered
12.2.3 Teva Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Teva Main Business Overview
12.2.5 Teva Latest Developments
12.3 Novartis
12.3.1 Novartis Company Information
12.3.2 Novartis Aminoglycosides Antibiotics Product Offered
12.3.3 Novartis Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Novartis Main Business Overview
12.3.5 Novartis Latest Developments
12.4 Fangyuan-pharma
12.4.1 Fangyuan-pharma Company Information
12.4.2 Fangyuan-pharma Aminoglycosides Antibiotics Product Offered
12.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Fangyuan-pharma Main Business Overview
12.4.5 Fangyuan-pharma Latest Developments
12.5 Aike Pharmaceutical
12.5.1 Aike Pharmaceutical Company Information
12.5.2 Aike Pharmaceutical Aminoglycosides Antibiotics Product Offered
12.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Aike Pharmaceutical Main Business Overview
12.5.5 Aike Pharmaceutical Latest Developments
12.6 Cipla
12.6.1 Cipla Company Information
12.6.2 Cipla Aminoglycosides Antibiotics Product Offered
12.6.3 Cipla Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Cipla Main Business Overview
12.6.5 Cipla Latest Developments
12.7 Pfizer
12.7.1 Pfizer Company Information
12.7.2 Pfizer Aminoglycosides Antibiotics Product Offered
12.7.3 Pfizer Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Pfizer Main Business Overview
12.7.5 Pfizer Latest Developments
12.8 Fresenius Kabi
12.8.1 Fresenius Kabi Company Information
12.8.2 Fresenius Kabi Aminoglycosides Antibiotics Product Offered
12.8.3 Fresenius Kabi Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Fresenius Kabi Main Business Overview
12.8.5 Fresenius Kabi Latest Developments
12.9 Sun Pharma
12.9.1 Sun Pharma Company Information
12.9.2 Sun Pharma Aminoglycosides Antibiotics Product Offered
12.9.3 Sun Pharma Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Sun Pharma Main Business Overview
12.9.5 Sun Pharma Latest Developments
12.10 Hikma
12.10.1 Hikma Company Information
12.10.2 Hikma Aminoglycosides Antibiotics Product Offered
12.10.3 Hikma Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Hikma Main Business Overview
12.10.5 Hikma Latest Developments
12.11 Lannett Company
12.11.1 Lannett Company Company Information
12.11.2 Lannett Company Aminoglycosides Antibiotics Product Offered
12.11.3 Lannett Company Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Lannett Company Main Business Overview
12.11.5 Lannett Company Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Aminoglycosides Antibiotics Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Neomycin
Table 3. Major Players of Tobramycin
Table 4. Major Players of Gentamicin
Table 5. Major Players of Amikacin
Table 6. Major Players of Etimicin
Table 7. Major Players of Others
Table 8. Global Aminoglycosides Antibiotics Sales by Type (2016-2021) & (M Units)
Table 9. Global Aminoglycosides Antibiotics Sales Market Share by Type (2016-2021)
Table 10. Global Aminoglycosides Antibiotics Revenue by Type (2016-2021) & ($ million)
Table 11. Global Aminoglycosides Antibiotics Revenue Market Share by Type (2016-2021)
Table 12. Global Aminoglycosides Antibiotics Sale Price by Type (2016-2021)
Table 13. Global Aminoglycosides Antibiotics Sales by Application (2016-2021) & (M Units)
Table 14. Global Aminoglycosides Antibiotics Sales Market Share by Application (2016-2021)
Table 15. Global Aminoglycosides Antibiotics Value by Application (2016-2021)
Table 16. Global Aminoglycosides Antibiotics Revenue Market Share by Application (2016-2021)
Table 17. Global Aminoglycosides Antibiotics Sale Price by Application (2016-2021)
Table 18. Global Aminoglycosides Antibiotics Sales by Company (2019-2021) & (M Units)
Table 19. Global Aminoglycosides Antibiotics Sales Market Share by Company (2019-2021)
Table 20. Global Aminoglycosides Antibiotics Revenue by Company (2019-2021) ($ Millions)
Table 21. Global Aminoglycosides Antibiotics Revenue Market Share by Company (2019-2021)
Table 22. Global Aminoglycosides Antibiotics Sale Price by Company (2019-2021)
Table 23. Key Manufacturers Aminoglycosides Antibiotics Producing Area Distribution and Sales Area
Table 24. Players Aminoglycosides Antibiotics Products Offered
Table 25. Aminoglycosides Antibiotics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Aminoglycosides Antibiotics Sales by Region (2016-2021) (M Units)
Table 29. Global Aminoglycosides Antibiotics Sales Market Share by Region (2016-2021)
Table 30. Global Aminoglycosides Antibiotics Revenue by Region (2016-2021) & ($ Millions)
Table 31. Global Aminoglycosides Antibiotics Revenue Market Share by Region (2016-2021)
Table 32. Americas Aminoglycosides Antibiotics Sales by Country (2016-2021) & (M Units)
Table 33. Americas Aminoglycosides Antibiotics Sales Market Share by Country (2016-2021)
Table 34. Americas Aminoglycosides Antibiotics Revenue by Country (2016-2021) & ($ Millions)
Table 35. Americas Aminoglycosides Antibiotics Revenue Market Share by Country (2016-2021)
Table 36. Americas Aminoglycosides Antibiotics Sales by Type (2016-2021) & (M Units)
Table 37. Americas Aminoglycosides Antibiotics Sales Market Share by Type (2016-2021)
Table 38. Americas Aminoglycosides Antibiotics Sales by Application (2016-2021) & (M Units)
Table 39. Americas Aminoglycosides Antibiotics Sales Market Share by Application (2016-2021)
Table 40. APAC Aminoglycosides Antibiotics Sales by Region (2016-2021) & (M Units)
Table 41. APAC Aminoglycosides Antibiotics Sales Market Share by Region (2016-2021)
Table 42. APAC Aminoglycosides Antibiotics Revenue by Region (2016-2021) & ($ Millions)
Table 43. APAC Aminoglycosides Antibiotics Revenue Market Share by Region (2016-2021)
Table 44. APAC Aminoglycosides Antibiotics Sales by Type (2016-2021) & (M Units)
Table 45. APAC Aminoglycosides Antibiotics Sales Market Share by Type (2016-2021)
Table 46. APAC Aminoglycosides Antibiotics Sales by Application (2016-2021) & (M Units)
Table 47. APAC Aminoglycosides Antibiotics Sales Market Share by Application (2016-2021)
Table 48. Europe Aminoglycosides Antibiotics Sales by Country (2016-2021) & (M Units)
Table 49. Europe Aminoglycosides Antibiotics Sales Market Share by Country (2016-2021)
Table 50. Europe Aminoglycosides Antibiotics Revenue by Country (2016-2021) & ($ Millions)
Table 51. Europe Aminoglycosides Antibiotics Revenue Market Share by Country (2016-2021)
Table 52. Europe Aminoglycosides Antibiotics Sales by Type (2016-2021) & (M Units)
Table 53. Europe Aminoglycosides Antibiotics Sales Market Share by Type (2016-2021)
Table 54. Europe Aminoglycosides Antibiotics Sales by Application (2016-2021) & (M Units)
Table 55. Europe Aminoglycosides Antibiotics Sales Market Share by Application (2016-2021)
Table 56. Middle East & Africa Aminoglycosides Antibiotics Sales by Country (2016-2021) & (M Units)
Table 57. Middle East & Africa Aminoglycosides Antibiotics Sales Market Share by Country (2016-2021)
Table 58. Middle East & Africa Aminoglycosides Antibiotics Revenue by Country (2016-2021) & ($ Millions)
Table 59. Middle East & Africa Aminoglycosides Antibiotics Revenue Market Share by Country (2016-2021)
Table 60. Middle East & Africa Aminoglycosides Antibiotics Sales by Type (2016-2021) & (M Units)
Table 61. Middle East & Africa Aminoglycosides Antibiotics Sales Market Share by Type (2016-2021)
Table 62. Middle East & Africa Aminoglycosides Antibiotics Sales by Application (2016-2021) & (M Units)
Table 63. Middle East & Africa Aminoglycosides Antibiotics Sales Market Share by Application (2016-2021)
Table 64. Global Aminoglycosides Antibiotics Sales Forecast by Type (2021-2026) & (M Units)
Table 65. Global Aminoglycosides Antibiotics Sales Market Share Forecast by Type (2021-2026)
Table 66. Global Aminoglycosides Antibiotics Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 67. Global Aminoglycosides Antibiotics Revenue Market Share Forecast by Type (2021-2026)
Table 68. Global Aminoglycosides Antibiotics Sales Forecast by Application (2021-2026) & (M Units)
Table 69. Global Aminoglycosides Antibiotics Sales Market Share Forecast by Application (2021-2026)
Table 70. Global Aminoglycosides Antibiotics Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 71. Global Aminoglycosides Antibiotics Revenue Market Share Forecast by Application (2021-2026)
Table 72. Jemicare Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 73. Jemicare Aminoglycosides Antibiotics Product Offered
Table 74. Jemicare Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 75. Jemicare Main Business
Table 76. Jemicare Latest Developments
Table 77. Teva Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 78. Teva Aminoglycosides Antibiotics Product Offered
Table 79. Teva Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 80. Teva Main Business
Table 81. Teva Latest Developments
Table 82. Novartis Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 83. Novartis Aminoglycosides Antibiotics Product Offered
Table 84. Novartis Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 85. Novartis Main Business
Table 86. Novartis Latest Developments
Table 87. Fangyuan-pharma Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 88. Fangyuan-pharma Aminoglycosides Antibiotics Product Offered
Table 89. Fangyuan-pharma Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 90. Fangyuan-pharma Main Business
Table 91. Fangyuan-pharma Latest Developments
Table 92. Aike Pharmaceutical Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 93. Aike Pharmaceutical Aminoglycosides Antibiotics Product Offered
Table 94. Aike Pharmaceutical Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 95. Aike Pharmaceutical Main Business
Table 96. Aike Pharmaceutical Latest Developments
Table 97. Cipla Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 98. Cipla Aminoglycosides Antibiotics Product Offered
Table 99. Cipla Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 100. Cipla Main Business
Table 101. Cipla Latest Developments
Table 102. Pfizer Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 103. Pfizer Aminoglycosides Antibiotics Product Offered
Table 104. Pfizer Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 105. Pfizer Main Business
Table 106. Pfizer Latest Developments
Table 107. Fresenius Kabi Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 108. Fresenius Kabi Aminoglycosides Antibiotics Product Offered
Table 109. Fresenius Kabi Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 110. Fresenius Kabi Main Business
Table 111. Fresenius Kabi Latest Developments
Table 112. Sun Pharma Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 113. Sun Pharma Aminoglycosides Antibiotics Product Offered
Table 114. Sun Pharma Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 115. Sun Pharma Main Business
Table 116. Sun Pharma Latest Developments
Table 117. Hikma Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 118. Hikma Aminoglycosides Antibiotics Product Offered
Table 119. Hikma Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 120. Hikma Main Business
Table 121. Hikma Latest Developments
Table 122. Lannett Company Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 123. Lannett Company Aminoglycosides Antibiotics Product Offered
Table 124. Lannett Company Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 125. Lannett Company Main Business
Table 126. Lannett Company Latest Developments
List of Figures
Figure 1. Picture of Aminoglycosides Antibiotics
Figure 2. Aminoglycosides Antibiotics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aminoglycosides Antibiotics Sales Growth Rate 2016-2026 (M Units)
Figure 7. Global Aminoglycosides Antibiotics Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Aminoglycosides Antibiotics Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Neomycin
Figure 10. Product Picture of Tobramycin
Figure 11. Product Picture of Gentamicin
Figure 12. Product Picture of Amikacin
Figure 13. Product Picture of Etimicin
Figure 14. Product Picture of Others
Figure 15. Global Aminoglycosides Antibiotics Sales Market Share by Type in 2020
Figure 16. Global Aminoglycosides Antibiotics Revenue Market Share by Type (2016-2021)
Figure 17. Aminoglycosides Antibiotics Consumed in Hospital
Figure 18. Global Aminoglycosides Antibiotics Market: Hospital (2016-2021) & (M Units)
Figure 19. Aminoglycosides Antibiotics Consumed in Clinic
Figure 20. Global Aminoglycosides Antibiotics Market: Clinic (2016-2021) & (M Units)
Figure 21. Aminoglycosides Antibiotics Consumed in Post Care Facility
Figure 22. Global Aminoglycosides Antibiotics Market: Post Care Facility (2016-2021) & (M Units)
Figure 23. Aminoglycosides Antibiotics Consumed in Government & Military
Figure 24. Global Aminoglycosides Antibiotics Market: Government & Military (2016-2021) & (M Units)
Figure 25. Aminoglycosides Antibiotics Consumed in Others
Figure 26. Global Aminoglycosides Antibiotics Market: Others (2016-2021) & (M Units)
Figure 27. Global Aminoglycosides Antibiotics Sales Market Share by Application (2016-2021)
Figure 28. Global Aminoglycosides Antibiotics Revenue Market Share by Application in 2020
Figure 29. Global Aminoglycosides Antibiotics Revenue Market by Company in 2020 ($ Million)
Figure 30. Global Aminoglycosides Antibiotics Revenue Market Share by Company in 2020
Figure 31. Global Aminoglycosides Antibiotics Sales Market Share by Regions (2016-2021)
Figure 32. Global Aminoglycosides Antibiotics Revenue Market Share by Region in 2020
Figure 33. Americas Aminoglycosides Antibiotics Sales 2016-2021 (M Units)
Figure 34. Americas Aminoglycosides Antibiotics Revenue 2016-2021 ($ Millions)
Figure 35. APAC Aminoglycosides Antibiotics Sales 2016-2021 (M Units)
Figure 36. APAC Aminoglycosides Antibiotics Revenue 2016-2021 ($ Millions)
Figure 37. Europe Aminoglycosides Antibiotics Sales 2016-2021 (M Units)
Figure 38. Europe Aminoglycosides Antibiotics Revenue 2016-2021 ($ Millions)
Figure 39. Middle East & Africa Aminoglycosides Antibiotics Sales 2016-2021 (M Units)
Figure 40. Middle East & Africa Aminoglycosides Antibiotics Revenue 2016-2021 ($ Millions)
Figure 41. Americas Aminoglycosides Antibiotics Sales Market Share by Country in 2020
Figure 42. Americas Aminoglycosides Antibiotics Revenue Market Share by Country in 2020
Figure 43. Americas Aminoglycosides Antibiotics Sales Market Share by Type in 2020
Figure 44. Americas Aminoglycosides Antibiotics Sales Market Share by Application in 2020
Figure 45. United States Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 46. Canada Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 47. Mexico Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 48. Brazil Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 49. APAC Aminoglycosides Antibiotics Sales Market Share by Region in 2020
Figure 50. APAC Aminoglycosides Antibiotics Revenue Market Share by Regions in 2020
Figure 51. APAC Aminoglycosides Antibiotics Sales Market Share by Type in 2020
Figure 52. APAC Aminoglycosides Antibiotics Sales Market Share by Application in 2020
Figure 53. China Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 54. Japan Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 55. Korea Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 56. Southeast Asia Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 57. India Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 58. Australia Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 59. Europe Aminoglycosides Antibiotics Sales Market Share by Country in 2020
Figure 60. Europe Aminoglycosides Antibiotics Revenue Market Share by Country in 2020
Figure 61. Europe Aminoglycosides Antibiotics Sales Market Share by Type in 2020
Figure 62. Europe Aminoglycosides Antibiotics Sales Market Share by Application in 2020
Figure 63. Germany Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 64. France Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 65. UK Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 66. Italy Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 67. Russia Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 68. Middle East & Africa Aminoglycosides Antibiotics Sales Market Share by Country in 2020
Figure 69. Middle East & Africa Aminoglycosides Antibiotics Revenue Market Share by Country in 2020
Figure 70. Middle East & Africa Aminoglycosides Antibiotics Sales Market Share by Type in 2020
Figure 71. Middle East & Africa Aminoglycosides Antibiotics Sales Market Share by Application in 2020
Figure 72. Egypt Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 73. South Africa Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 74. Israel Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 75. Turkey Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 76. GCC Country Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles

※본 조사보고서 [세계의 아미노글리코사이드계 항생제 시장예측 2021년-2026년] (코드 : LPI-2108K202098) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 아미노글리코사이드계 항생제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 의약품용 자일리톨 시장예측 2021년-2026년
LPI-2108K201689 / LP Information / 2021년 8월 / 본 조사보고서는 의약품용 자일리톨의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Pharma Grade Xylitol will have significant change from previous year. By the most conservative estimates of global Pharma Grade Xylitol market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 세팔 렉신 캡슐 시장예측 2021년-2026년
LPI-2108K200016 / LP Information / 2021년 8월 / 본 조사보고서는 세팔 렉신 캡슐의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Cephalexin Capsules will have significant change from previous year. By the most conservative estimates of global Cephalexin Capsules market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over...

세계의 무침 약물 전달 시스템 시장예측 2021년-2026년
LPI-2108K201631 / LP Information / 2021년 8월 / 본 조사보고서는 무침 약물 전달 시스템의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2020 growth of Needle-Free Drug Delivery Systems will have significant change from previous year. By the most conservative estimates of global Needle-Free Drug Delivery Systems market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx...

세계의 안검염용 파이프 라인 시장예측 2021년-2026년
LPI-2108K200064 / LP Information / 2021년 8월 / 본 조사보고서는 안검염용 파이프 라인의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Blepharitis-Pipeline will have significant change from previous year. By the most conservative estimates of global Blepharitis-Pipeline market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next...

세계의 할로페리돌 시장예측 2021년-2026년
LPI-2108K200026 / LP Information / 2021년 8월 / 본 조사보고서는 할로페리돌의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2020 growth of Haloperidol will have significant change from previous year. By the most conservative estimates of global Haloperidol market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next...

세계의 클라드리빈 시장예측 2021년-2026년
LPI-2108K201197 / LP Information / 2021년 8월 / 본 조사보고서는 클라드리빈의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2021 growth of Cladribine will have significant change from previous year. By the most conservative estimates of global Cladribine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next...

세계의 메타프로테레놀 시장예측 2021년-2026년
LPI-2108K201583 / LP Information / 2021년 8월 / 본 조사보고서는 메타프로테레놀의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2021 growth of Metaproterenol will have significant change from previous year. By the most conservative estimates of global Metaproterenol market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next...

세계의 데메롤 (메페리딘) 시장예측 2021년-2026년
LPI-2108K201259 / LP Information / 2021년 8월 / 본 조사보고서는 데메롤 (메페리딘)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Demerol (Meperidine) will have significant change from previous year. By the most conservative estimates of global Demerol (Meperidine) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over...

세계의 경피 니코틴 패치 시장예측 2021년-2026년
LPI-2108K201925 / LP Information / 2021년 8월 / 본 조사보고서는 경피 니코틴 패치의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Transdermal Nicotine Patch will have significant change from previous year. By the most conservative estimates of global Transdermal Nicotine Patch market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 양극성 장애 약물 시장예측 2021년-2026년
LPI-2108K202119 / LP Information / 2021년 8월 / 본 조사보고서는 양극성 장애 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Bipolar Disorder Drugs will have significant change from previous year. By the most conservative estimates of global Bipolar Disorder Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...